Archives

by in
Entry Author Date Location
Novartis, Trying Not to Burn the Hamburger, Increases its Bet on the Bay Area 04/19/11 San Francisco
Gilead Drug Fails AIDS Prevention Trial 04/18/11 San Francisco
Tobira Pegs Nodality Vet Andrew Hindman as CEO 04/04/11 New York
Gilead Inks $100M Deal With Yale 03/31/11 San Francisco
Gilead Pursues Cancer, Inflammation as Next Step To Diversify Beyond HIV 02/23/11 San Francisco
Calistoga Hands the Keys to Gilead, Bets It Can Make Cancer a Chronic Disease Like HIV 02/23/11 Seattle
Gilead Buys Calistoga Pharma for $375M, Making Move Into Cancer Drugs 02/22/11 Seattle
Quanterix, Novartis Test Out Super-Sensitive Diagnostic Tool for Neuro Disorder 02/22/11 Boston
Theraclone Strikes $632M Deal With Pfizer to Discover Antibodies for Cancer, Infections 01/18/11 Seattle
State Awards Global Health Grants 01/12/11 Seattle
Genzyme Initiates Job Cuts, Dana-Farber/Gatekeeper Suit Advances, GTC Bought by LFB, & More Boston-Area Life Sciences News 11/12/10 Boston
EMC Acquisitions Could Include Isilon, LFB Buys GTC, Tremor Media Snaps Up ScanScout, & More Boston-Area Deals News 11/10/10 Boston
Daktari Brings In $1.8M 11/05/10 Boston
Biogen Announces Restructuring, FDA Approves Sunovion Drug, Acceleron Cuts Workforce, & More Boston-Area Life Sciences News 11/05/10 Boston
ChemoCentryx, Pursuing the Dream For Autoimmune Disease, Seeks to Put a Pill in a Bottle 11/04/10 San Francisco
$20M Series A For Karyopharm to Fight Cancer 11/03/10 Boston
Dana Farber Gets $33M from Sanofi, Astellas Backs DecImmune, Ironwood Sells Microbia, & More Boston-Area Deals News 09/29/10 Boston
Genentech Inks Antibody Deal, Cytokinetics Sticks With Science First, BioMarin Scraps Drug, & More Bay Area Life Sciences News 08/06/10 San Francisco
Dendreon Shows Provenge Demand, Seattle Genetics Inks Big Deal, Corey Gets Top Hutch Job, & More Seattle-Area Life Sciences News 08/05/10 Seattle
Larry Corey, Virus Hunter With Midwest Roots, Seeks to Unleash Health Innovation at Hutch 08/02/10 Seattle
Gates Foundation’s Tachi Yamada: Biotechies and VCs are Missing Out on Global Health 07/30/10 Seattle
LS9 Reveals Key Biofuel Genes, Onyx Drug Passes Big Trial, Solazyme Seeks First-Mover Edge, & More Bay Area Life Sciences News 07/30/10 San Francisco
Gilead Borrowing $2.2B 07/26/10 San Francisco
Concert Pharma Riding Potential $1B Glaxo Deal, Looks Ahead to Human Data on HIV Drug 07/14/10 Boston
Accelerator, Taking a Break from Curing Cancer, Unwinds With Some Mini-Golf Hijinks 07/12/10 Seattle
Jackpot Scores $14M, MIT Startup Wins 20K-Euro Prize, Nuance Acquires ShapeWriter, & More Boston-Area Deals News 06/23/10 Boston
Gilead CF Drug Passes Trial 06/18/10 San Francisco
Curis Misses Mark in Cancer Drug Trial, Genzyme Re-Elects Full Board, GTC Cuts Jobs, & More Boston-Area Life Sciences News 06/18/10 Boston
Daktari Diagnostics, Backed by Gates Foundation, Raises Funds for HIV Test Study 06/17/10 Boston
Theraclone Sciences CEO David Fanning Dies Suddenly 06/14/10 Seattle
Page 2 of 5 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Do You Need an Extended Warranty? Do the Math, Says SquareTrade

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.